Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2016, Vol. 10 ›› Issue (03): 231-234. doi: 10.3877/cma.j.issn.1674-0793.2016.03.018

Special Issue:

• Evidence-based Version • Previous Articles    

Clinical significance of antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: a meta-analysis

Yijie Li1, Guowei Li2, Xinfeng Huang3, Qingan Zeng1,()   

  1. 1. The Second Department of General Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China
    2. the Second Department of Orthopeadic Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China
    3. Department of Plastic Surgery, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China
  • Received:2016-01-18 Online:2016-06-01 Published:2016-06-01
  • Contact: Qingan Zeng
  • About author:
    Corresponding author: Zeng Qingan, Email:

Abstract:

Objective

To assess the infectious complications of antibiotic prophylaxis following transcatheter arterial chemoembolization (TACE) for patients with primary hepatocellular carcinoma (HCC).

Methods

All studies that have been published comparing the effects of prophylactic antibiotic treatment (study group) and no prophylactic antibiotic treatment (control group) on infectious complications in pa-tients with HCC following TACE were searched and evaluated strictly in rash quality, then the adopted stud-ies were analyzed by Meta-analysis. The risk ratio (RR) for infectious complications between the two groups were calculated.

Results

Totally four studies including 1 358 cases were analyzed. The cumulative cases in prophylactic antibiotic treatment group were 960, 83 of whom were reported postoperative infection, while in the control group, the number was 398 and 43 respectively. The pooled RR was 0.88, with a 95% confidence interval (0.62-1.24).

Conclusion

It is not routinely necessary for HCC patients to undergo an-tibotic prophylaxis following TACE.

Key words: Carcinoma, hepatocellular, Chemoembolization, therapeutic, Antibotic prophylaxis, Anti-bacterial agents, Meta-analysis

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd